Trial Profile
Efficacy, safety and pharmacokinetics of raltegravir in patients with HIV infections and cancer receiving antineoplastic chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary) ; Abacavir; Antineoplastics; Emtricitabine; Lamivudine; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Pharmacokinetics; Therapeutic Use
- 09 Nov 2015 New trial record